dc.contributor
Institut Català de la Salut
dc.contributor
[Busca A] Stem Cell Transplant Center, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Turin, Italy. [Salmanton-García J] Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine and University Hospital Cologne, Cologne, Germany. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University Hospital Cologne, Cologne, Germany. [Corradini P] University of Milan and Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy. [Marchesi F] Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. [Cabirta A] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Di Blasi R] Hôpital Saint Louis, Assistance Publique–Hopitaux de Paris (AP-HP), Paris, France
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Busca, Alessandro
dc.contributor.author
Salmanton-García, Jon
dc.contributor.author
Corradini, Paolo
dc.contributor.author
Di Blasi, Roberta
dc.contributor.author
Marchesi, Francesco
dc.contributor.author
Cabirta, Alba
dc.date.accessioned
2023-11-08T10:19:53Z
dc.date.available
2023-11-08T10:19:53Z
dc.date.issued
2023-05-18T12:20:43Z
dc.date.issued
2023-05-18T12:20:43Z
dc.date.issued
2022-04-12
dc.identifier
Busca A, Salmanton-Garcıa J, Corradini P, Marchesi F, Cabirta A, Blasi R Di, et al. COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP. Blood Adv. 2022 Apr 12;6(7):2427–33.
dc.identifier
https://hdl.handle.net/11351/9565
dc.identifier
10.1182/bloodadvances.2021005616
dc.identifier.uri
https://hdl.handle.net/11351/9565
dc.description.abstract
COVID-19; CAR T cells
dc.description.abstract
COVID-19; Cèl·lules CAR T
dc.description.abstract
COVID-19; Células CAR T
dc.description.abstract
EPICOVIDEHA has received funds from the Optics COMMITTM (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by Gilead Sciences (Foster City, CA; project 2020-8223).
dc.format
application/pdf
dc.relation
Blood Advances;6(7)
dc.relation
https://doi.org/10.1182/bloodadvances.2021005616
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Teràpia cel·lular
dc.subject
COVID-19 (Malaltia)
dc.subject
DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections
dc.subject
ANATOMY::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive
dc.subject
ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus
dc.subject
ANATOMÍA::células::células sanguíneas::leucocitos::leucocitos mononucleares::linfocitos::linfocitos T
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva
dc.title
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
